Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 30, 2000 - Issue 6
Submit an article Journal homepage
105
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human

K. Beaumont Department of Drug Metabolism, Pfizer Central Research, Sandwich CT13 9NJ, UK
,
A. Harper Early Clinical Research Group, Pfizer Central Research, Sandwich CT13 9NJ, UK
,
D. A. Smith Department of Drug Metabolism, Pfizer Central Research, Sandwich CT13 9NJ, UK
&
S. Abel Early Clinical Research Group, Pfizer Central Research, Sandwich CT13 9NJ, UK
Pages 627-642 | Published online: 22 Sep 2008

References

  • BERGQVIST, Y. and DOMEIJ-NYBERG, B., 1983, Distribution of chloroquine and its metabolite desethylchloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. Journal of Chromatography, 272, 137–148.
  • CHAN, O. H. and STEWART, B. H., 1996, Physicochemical and drug-delivery considerations for oral drug bioavailability. Drug Discovery Today, 1, 461–473.
  • HALL, S. D., THUMMEL, K. E., WATKINS, P. B., LOWN, K. S., BENET, L. Z., PAINE, M. F., MAYO, R. R., TURGEON, D. K., BAILEY, D. G., FONTANA, R. J. and WRIGHTON, S. A., 1999, Molecular and physical mechanisms of first-pass extraction. Drug Metabolism and Disposition, 27, 161–166.
  • HE, Y., MURBY, S., WARHURST, G., GIFFORD, L, WALKER, D., AYRTON, J., EASTMOND, R. and ROWLAND, M., 1998, Species differences in size discrimination in the paracellular pathway reflected by oral bioavailability of polyethylene glycol and ID-peptides. Journal of Pharmaceutical Sciences, 87, 626–633.
  • HEBERT, M. F., 1997, Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery. Advanced Drug Delivery Reviews, 27, 201–214. HINDERLING, P. H., 1997, Red blood cells: a neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacology Reviews, 49, 279–295.
  • LAMPEN, A., ZHANG, Y., HACKBARTH, I., BENET, L. Z., SEWING K.-F. and CHRISTIANS, U., 1998, Metabolism and transport of the macrolide immunosuppressant sirolimus in the small intestine. Journal of Pharmacology and Experimental Therapeutics, 285, 1104–1112.
  • LETTIERI, J. T., and PORTELLI, S. T., 1983, Effects of competitive red blood cell binding and reduced haematocrit on the blood and plasma levels of ['AC] -indapamide in the rat. Journal of Pharmacology and Experimental Therapeutics, 224, 266–272.
  • LIPINSKI, C. A., LOMBARDO, F., DOMINY, B. W. and FEENEY, P. J., 1997, Experimental and com-putational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
  • LOWN, K. 5, BAILEY, D. G., FONTANA, R. J., JANARDEN,S. K., ADAIR, C. H., FORTLAGE, L. A., BROWN, M. B., Guo, W. and WATKINS P. B., 1997, Grapefruit juice increase felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. Journal of Clinical Investigation, 99, 2545–2553.
  • SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25, 451–523.
  • SEELIG, A., 1998, A general pattern for substrate recognition by P-glycoprotein. European Journal of Biochemistry, 251, 252–261.
  • SHAH, V. P., MIDHA, K. K., DIGHE, S., MCGILVERAY, I. J., SKELLEY, J. P., YACOBI, A., LAYLOFF, T., VISWANATHAN, C. T., COOK, C. E., McDowALL, R. D., PITTMAN, K. A. and SPECTOR, S., 1997, Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. Journal of Pharmaceutical Sciences, 81, 309–312.
  • VAN ASPEREN, J., VAN TELLINGEN, O. and BEIJNEN, J. H., 1998, The pharmacological role of P-glycoprotein in the intestinal epithelium. Pharmacology Research, 37, 429–435.
  • WACHER, V. J., SALPHATI, L. and BENET, L. Z., 1996, Active secretion and enterocytic drug metabolism barriers to drug absorption. Advanced Drug Delivery Reviews, 20, 99–112.
  • WACHER, V. J., SILVERMAN, J. A., ZHANG, Y. and BENET, L. Z., 1998, Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics. Journal of Pharmaceutical Sciences, 87, 1322–1330.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.